Max Donley
2020 - Aurinia Pharmaceuticals
In 2020, Max Donley earned a total compensation of $3.3M as EVP, Operations and Strategy at Aurinia Pharmaceuticals, a 253% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $239,575 |
|---|---|
| Option Awards | $2,249,253 |
| Salary | $383,320 |
| Stock Awards | $461,040 |
| Other | $4,615 |
| Total | $3,337,803 |
Donley received $2.2M in option awards, accounting for 67% of the total pay in 2020.
Donley also received $239.6K in non-equity incentive plan, $383.3K in salary, $461K in stock awards and $4.6K in other compensation.
Rankings
In 2020, Max Donley's compensation ranked 3,489th out of 13,090 executives tracked by ExecPay. In other words, Donley earned more than 73.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,489 out of 13,090 | 73rd |
Division Manufacturing | 1,365 out of 5,618 | 76th |
Major group Chemicals And Allied Products | 513 out of 2,251 | 77th |
Industry group Drugs | 446 out of 1,951 | 77th |
Industry Pharmaceutical Preparations | 334 out of 1,456 | 77th |
Source: SEC filing on May 10, 2021.
Donley's colleagues
We found five more compensation records of executives who worked with Max Donley at Aurinia Pharmaceuticals in 2020.
2020
Peter Greenleaf
Aurinia Pharmaceuticals
Chief Executive Officer
2020
Max Colao
Aurinia Pharmaceuticals
Chief Commercial Officer
2020
Joe Miller
Aurinia Pharmaceuticals
Chief Financial Officer
2020
Stephen Robertson
Aurinia Pharmaceuticals
General Counsel
2020
Dennis Bourgeault
Aurinia Pharmaceuticals